Literature DB >> 25596828

De novo formed satellite DNA-based mammalian artificial chromosomes and their possible applications.

Robert L Katona1.   

Abstract

Mammalian artificial chromosomes (MACs) are non-integrating, autonomously replicating natural chromosome-based vectors that may carry a vast amount of genetic material, which in turn enable potentially prolonged, safe, and regulated therapeutic transgene expression and render MACs as attractive genetic vectors for "gene replacement" or for controlling differentiation pathways in target cells. Satellite-DNA-based artificial chromosomes (SATACs) can be made by induced de novo chromosome formation in cells of different mammalian and plant species. These artificially generated accessory chromosomes are composed of predictable DNA sequences, and they contain defined genetic information. SATACs have already passed a number of obstacles crucial to their further development as gene therapy vectors, including large-scale purification, transfer of purified artificial chromosomes into different cells and embryos, generation of transgenic animals and germline transmission with purified SATACs, and the tissue-specific expression of a therapeutic gene from an artificial chromosome in the milk of transgenic animals. SATACs could be used in cell therapy protocols. For these methods, the most versatile target cell would be one that was pluripotent and self-renewing to address multiple disease target cell types, thus making multilineage stem cells, such as adult derived early progenitor cells and embryonic stem cells, as attractive universal host cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25596828     DOI: 10.1007/s10577-014-9458-0

Source DB:  PubMed          Journal:  Chromosome Res        ISSN: 0967-3849            Impact factor:   5.239


  207 in total

1.  Human artificial chromosomes: emerging from concept to reality in biomedicine.

Authors:  Mes Lewis
Journal:  Clin Genet       Date:  2001-01       Impact factor: 4.438

2.  Efficient differentiation of human embryonic stem cells to definitive endoderm.

Authors:  Kevin A D'Amour; Alan D Agulnick; Susan Eliazer; Olivia G Kelly; Evert Kroon; Emmanuel E Baetge
Journal:  Nat Biotechnol       Date:  2005-10-28       Impact factor: 54.908

Review 3.  Progress and prospects: human artificial chromosomes.

Authors:  S Macnab; A Whitehouse
Journal:  Gene Ther       Date:  2009-08-27       Impact factor: 5.250

4.  Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response.

Authors:  M Christ; M Lusky; F Stoeckel; D Dreyer; A Dieterlé; A I Michou; A Pavirani; M Mehtali
Journal:  Immunol Lett       Date:  1997-06-01       Impact factor: 3.685

5.  Human embryonic stem cell lines derived from single blastomeres.

Authors:  Irina Klimanskaya; Young Chung; Sandy Becker; Shi-Jiang Lu; Robert Lanza
Journal:  Nature       Date:  2006-08-23       Impact factor: 49.962

6.  Chamber-specific differentiation of Nkx2.5-positive cardiac precursor cells from murine embryonic stem cells.

Authors:  Kyoko Hidaka; Jong-Kook Lee; Hoe Suk Kim; Chun Hwa Ihm; Akio Iio; Minetaro Ogawa; Shin-Ichi Nishikawa; Itsuo Kodama; Takayuki Morisaki
Journal:  FASEB J       Date:  2003-02-19       Impact factor: 5.191

7.  Human artificial chromosome (HAC) vector provides long-term therapeutic transgene expression in normal human primary fibroblasts.

Authors:  M Kakeda; M Hiratsuka; K Nagata; Y Kuroiwa; M Kakitani; M Katoh; M Oshimura; K Tomizuka
Journal:  Gene Ther       Date:  2005-05       Impact factor: 5.250

8.  A DA/DAPI positive human 14p heteromorphism defined by fluorescence in-situ hybridisation using chromosome 15-specific probes D15Z1 (satellite III) and p-TRA-25 (alphoid).

Authors:  K Stergianou; C P Gould; J J Waters; M A Hultén
Journal:  Hereditas       Date:  1993       Impact factor: 3.271

9.  Adeno-associated virus vectors integrate at chromosome breakage sites.

Authors:  Daniel G Miller; Lisa M Petek; David W Russell
Journal:  Nat Genet       Date:  2004-06-20       Impact factor: 38.330

10.  Microcell-mediated transfer of murine chromosomes into mouse, Chinese hamster, and human somatic cells.

Authors:  R E Fournier; F H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

View more
  7 in total

1.  Human artificial chromosomes for future biomedicine.

Authors:  Robert L Katona
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 2.  Transformation-associated recombination (TAR) cloning for genomics studies and synthetic biology.

Authors:  Natalay Kouprina; Vladimir Larionov
Journal:  Chromosoma       Date:  2016-04-26       Impact factor: 4.316

3.  Method to Assemble Genomic DNA Fragments or Genes on Human Artificial Chromosome with Regulated Kinetochore Using a Multi-Integrase System.

Authors:  Nicholas C O Lee; Jung-Hyun Kim; Nikolai S Petrov; Hee-Sheung Lee; Hiroshi Masumoto; William C Earnshaw; Vladimir Larionov; Natalay Kouprina
Journal:  ACS Synth Biol       Date:  2017-08-24       Impact factor: 5.110

4.  Assembly of Multiple Full-Size Genes or Genomic DNA Fragments on Human Artificial Chromosomes Using the Iterative Integration System.

Authors:  Nicholas C O Lee; Nikolai S Petrov; Vladimir Larionov; Natalay Kouprina
Journal:  Curr Protoc       Date:  2021-12

5.  Development of a novel HAC-based "gain of signal" quantitative assay for measuring chromosome instability (CIN) in cancer cells.

Authors:  Jung-Hyun Kim; Hee-Sheung Lee; Nicholas C O Lee; Nikolay V Goncharov; Vadim Kumeiko; Hiroshi Masumoto; William C Earnshaw; Natalay Kouprina; Vladimir Larionov
Journal:  Oncotarget       Date:  2016-03-22

6.  Moving toward a higher efficiency of microcell-mediated chromosome transfer.

Authors:  Mikhail Liskovykh; Nicholas Co Lee; Vladimir Larionov; Natalay Kouprina
Journal:  Mol Ther Methods Clin Dev       Date:  2016-06-22       Impact factor: 6.698

Review 7.  Human Artificial Chromosome with Regulated Centromere: A Tool for Genome and Cancer Studies.

Authors:  Natalay Kouprina; Nikolai Petrov; Oscar Molina; Mikhail Liskovykh; Elisa Pesenti; Jun-Ichirou Ohzeki; Hiroshi Masumoto; William C Earnshaw; Vladimir Larionov
Journal:  ACS Synth Biol       Date:  2018-08-16       Impact factor: 5.110

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.